Patent · US Active

Aryl hydrocarbon receptor (AhR) agonists for the prevention and treatment of inflammatory disorders

US11458141B2 · kind B2 · utility

0Cited by

3References

9Claims

0Family size

Assignee

THE JOHNS HOPKINS UNIVERSITY · US

Inventors

David J. Hackam · Pittsburgh, US
Peng-Cheng Lu · Timonium, US
Chhinder P. Sodhi · Columbia, US
Jun O. Liu · Clarksville, US

Key dates

Filing date	May 25, 2018
Grant date	Oct 4, 2022
Priority date	—
Expiry date	May 25, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Aryl hydrocarbon receptor (AHR) agonists and their use for treating, preventing, or reducing the risk of necrotizing enterocolitis in premature infants are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.